-
Je něco špatně v tomto záznamu ?
Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study
O. Bradáč, T. Zimmermann, JV. Burda,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- chemické modely MeSH
- kinetika MeSH
- kvantová teorie MeSH
- ligandy MeSH
- molekulární modely MeSH
- organoplatinové sloučeniny chemie MeSH
- oxidace-redukce MeSH
- protinádorové látky chemie MeSH
- termodynamika MeSH
- voda chemie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Hydration reactions of two anticancer Pt(IV) complexes JM149 and JM216 (Satraplatin) were studied computationally together with the hydration of the Pt(II) complex JM118, which is a product of the Satraplatin reduction. Thermodynamic and kinetic parameters of the reactions were determined at the B3LYP/6-311++G(2df.2pd)//B3LYP/6-31 + G(d)) level of theory. The water solution was modeled using the COSMO implicit solvation model, with cavities constructed using Klamt's atomic radii. It was found that hydration of the Pt(IV) complexes is an endergonic/endothermic reaction. It follows the (pseudo)associative mechanism is substantially slower (k ≈ 10(-11) s(-1)) than the corresponding reaction of Pt(II) analogues ((k ≈ 10(-5) s(-1)). Such a low value of the reaction constant signifies that the hydration of JM149 and Satraplatin is with high probability a kinetically forbidden reaction. Similarly to JM149 and Satraplatin, the hydration of JM118 is an endothermic/endoergic reaction. On the other hand, the kinetic parameters are similar to those of cisplatin Zimmermann et al. (J Mol Model 17:2385-2393, 2011), allowing the hydration reaction to occur at physiological conditions. These results suggest that in order to become active Satraplatin has to be first reduced to JM118, which may be subsequently hydrated to yield the active species.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14064265
- 003
- CZ-PrNML
- 005
- 20140709122901.0
- 007
- ta
- 008
- 140704s2013 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00894-012-1442-z $2 doi
- 035 __
- $a (PubMed)22643969
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Bradáč, Ondřej $u Department of Chemical Physics and Optics, Faculty of Mathematics and Physics, Charles University, Ke Karlovu 3, 121 16, Prague 2, Czech Republic.
- 245 10
- $a Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study / $c O. Bradáč, T. Zimmermann, JV. Burda,
- 520 9_
- $a Hydration reactions of two anticancer Pt(IV) complexes JM149 and JM216 (Satraplatin) were studied computationally together with the hydration of the Pt(II) complex JM118, which is a product of the Satraplatin reduction. Thermodynamic and kinetic parameters of the reactions were determined at the B3LYP/6-311++G(2df.2pd)//B3LYP/6-31 + G(d)) level of theory. The water solution was modeled using the COSMO implicit solvation model, with cavities constructed using Klamt's atomic radii. It was found that hydration of the Pt(IV) complexes is an endergonic/endothermic reaction. It follows the (pseudo)associative mechanism is substantially slower (k ≈ 10(-11) s(-1)) than the corresponding reaction of Pt(II) analogues ((k ≈ 10(-5) s(-1)). Such a low value of the reaction constant signifies that the hydration of JM149 and Satraplatin is with high probability a kinetically forbidden reaction. Similarly to JM149 and Satraplatin, the hydration of JM118 is an endothermic/endoergic reaction. On the other hand, the kinetic parameters are similar to those of cisplatin Zimmermann et al. (J Mol Model 17:2385-2393, 2011), allowing the hydration reaction to occur at physiological conditions. These results suggest that in order to become active Satraplatin has to be first reduced to JM118, which may be subsequently hydrated to yield the active species.
- 650 _2
- $a protinádorové látky $x chemie $7 D000970
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a chemické modely $7 D008956
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a organoplatinové sloučeniny $x chemie $7 D009944
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a kvantová teorie $7 D011789
- 650 _2
- $a termodynamika $7 D013816
- 650 _2
- $a voda $x chemie $7 D014867
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zimmermann, Tomáš
- 700 1_
- $a Burda, Jaroslav V
- 773 0_
- $w MED00005762 $t Journal of molecular modeling $x 0948-5023 $g Roč. 19, č. 11 (2013), s. 4669-80
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22643969 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20140709123153 $b ABA008
- 999 __
- $a ok $b bmc $g 1031749 $s 862997
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 19 $c 11 $d 4669-80 $i 0948-5023 $m Journal of molecular modeling $n J Mol Model $x MED00005762
- LZP __
- $a Pubmed-20140704